- Home
- BIAF vs SMTK Comparison
BIAF vs SMTK Comparison
Compare BIAF & SMTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIAF
- SMTK
- Stock Information
- Founded
- BIAF 2014
- SMTK 2009
- Country
- BIAF United States
- SMTK United Kingdom
- Employees
- BIAF N/A
- SMTK N/A
- Industry
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SMTK
- Sector
- BIAF Health Care
- SMTK
- Exchange
- BIAF Nasdaq
- SMTK NYSE
- Market Cap
- BIAF 14.5M
- SMTK 13.3M
- IPO Year
- BIAF 2022
- SMTK N/A
- Fundamental
- Price
- BIAF $0.67
- SMTK $3.53
- Analyst Decision
- BIAF Strong Buy
- SMTK
- Analyst Count
- BIAF 1
- SMTK 0
- Target Price
- BIAF $6.00
- SMTK N/A
- AVG Volume (30 Days)
- BIAF 298.9K
- SMTK 95.6K
- Earning Date
- BIAF 11-14-2024
- SMTK 02-12-2025
- Dividend Yield
- BIAF N/A
- SMTK N/A
- EPS Growth
- BIAF N/A
- SMTK N/A
- EPS
- BIAF N/A
- SMTK N/A
- Revenue
- BIAF $9,367,785.00
- SMTK $40,000.00
- Revenue This Year
- BIAF $285.51
- SMTK N/A
- Revenue Next Year
- BIAF $20.05
- SMTK N/A
- P/E Ratio
- BIAF N/A
- SMTK N/A
- Revenue Growth
- BIAF 2813.87
- SMTK 471.43
- 52 Week Low
- BIAF $0.64
- SMTK $2.01
- 52 Week High
- BIAF $3.62
- SMTK $13.00
- Technical
- Relative Strength Index (RSI)
- BIAF 26.36
- SMTK N/A
- Support Level
- BIAF $0.64
- SMTK N/A
- Resistance Level
- BIAF $1.01
- SMTK N/A
- Average True Range (ATR)
- BIAF 0.07
- SMTK 0.00
- MACD
- BIAF -0.01
- SMTK 0.00
- Stochastic Oscillator
- BIAF 5.99
- SMTK 0.00
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.